EZH2 and neuroblastoma: Since histone lysine methylation levels are determined by the balance between the activities of histone lysine methyltransferases and demethylases22,23, we reasoned that histone lysine demethylases (KDMs) that antagonize the activity of EZH2 by removing H3K27me3 might have an onco-suppressor function in neuroblastoma.